INTERLEUKIN-1 AND INTERLEUKIN-6 ACTIVITIES ARE INCREASED IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH CNS LUPUS-ERYTHEMATOSUS AND CORRELATE WITH LOCAL LATE T-CELL ACTIVATION MARKERS

被引:73
作者
ALCOCERVARELA, J
ALEMANHOEY, D
ALARCONSEGOVIA, D
机构
[1] Department of Immunology and Rheumatology, Instituto Nacional de la Nutrición Salvador Zubirán, D.F.
关键词
INTERLEUKIN-1; T-CELL ACTIVATION; CNS LUPUS ERYTHEMATOSUS; CSF CYTOKINES; INTERLEUKIN-6; TUMOR NECROSIS FACTOR;
D O I
10.1177/096120339200100209
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined cerebrospinal fluid (CSF) samples from 12 patients with SLE and active central nervous system (CNS) involvement for their levels of the following cytokines: interleukin-1 (IL-1) by means of two different assays-the IL-1 responsive murine cell line LBRM 33-la5 and an ELISA for IL-1 alpha; IL-2 by means of the CTLL cell line responsive to it; and interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) both determined by a specific ELISA. We found that SLE CSF had significantly higher levels of IL-1 and IL-6 than did those obtained at surgery from eight controls without inflammatory neurologic disease. IL-2 and TNF were not detectable in any of the CSF samples. We also studied the status of activation in CSF T cells using monoclonal antibodies against early (anti-IL-2R (CD25) and anti-transferrin (CD71)), late (anti-T10) and very late (anti-VLA-1) activation antigens, and found increased percentages of T10-bearing (18 +/- 2 vs 3 +/- 0.7%) and VLA-1-bearing T cells (12 +/- 2 vs 0.7 +/- 0.2%) in SLE patients as compared to controls (both P < 0.01). Levels of IL-1 and IL-6 correlated with T10 and those of IL-1 correlated also with VLA-1. Markers of early T-cell activation did not differ in SLE and control CSF. Because of these findings we analysed the effect of recombinant IL-1, IL-6 or normal CSF on normal T cells and found that they did not induce the expression of activation markers. However, incubation in SLE CSF caused CD25, T10 and VLA-1 activation markers to become significantly expressed on cultured normal T cells. This expression of T10 and VLA-1 was partially inhibited by pre-incubation in anti-human IL-1 alpha polyvalent antibody. Our findings suggest increased in situ production of IL-1 and IL-6 and perhaps other factors in CNS lupus that might condition T-cell activation in the CNS compartment. These findings could have pathogenetic significance.
引用
收藏
页码:111 / 117
页数:7
相关论文
共 30 条
[21]   BINDING-SITES FOR IMMUNE COMPONENTS IN HUMAN CHOROID-PLEXUS [J].
PERESS, NS ;
ROXBURGH, VA ;
GELFAND, MC .
ARTHRITIS AND RHEUMATISM, 1981, 24 (03) :520-526
[22]   SERUM AND CEREBRAL SPINAL FLUID COMPLEMENT AND SERUM AUTOANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS [J].
PETZ, LD ;
SHARP, GC ;
COOPER, NR ;
IRVIN, WS .
MEDICINE, 1971, 50 (04) :259-+
[23]   VERY LATE ACTIVATION ANTIGENS (VLA) ARE HUMAN LEUKOCYTE-NEURONAL CROSS-REACTIVE CELL-SURFACE ANTIGENS [J].
PISCHEL, KD ;
BLUESTEIN, HG ;
WOODS, VL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (02) :393-406
[24]   MONOKINE PRODUCTION BY MICROGLIAL CELL CLONES [J].
RIGHI, M ;
MORI, L ;
DELIBERO, G ;
SIRONI, M ;
BIONDI, A ;
MANTOVANI, A ;
DONINI, SD ;
RICCIARDICASTAGNOLI, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (08) :1443-1448
[25]  
SANCHEZMADRID F, 1985, J IMMUNOL, V135, P3938
[26]   3 DISTINCT ANTIGENS ASSOCIATED WITH HUMAN LYMPHOCYTE-T-MEDIATED CYTOLYSIS - LFA-1, LFA-2, AND LFA-3 [J].
SANCHEZMADRID, F ;
KRENSKY, AM ;
WARE, CF ;
ROBBINS, E ;
STROMINGER, JL ;
BURAKOFF, SJ ;
SPRINGER, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (23) :7489-7493
[27]  
SIRONI M, 1989, J IMMUNOL, V142, P549
[28]   SPECIAL ARTICLE - THE 1982 REVISED CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
TAN, EM ;
COHEN, AS ;
FRIES, JF ;
MASI, AT ;
MCSHANE, DJ ;
ROTHFIELD, NF ;
SCHALLER, JG ;
TALAL, N ;
WINCHESTER, RJ .
ARTHRITIS AND RHEUMATISM, 1982, 25 (11) :1271-1277
[29]   BIOCHEMICAL-STUDIES OF THE HUMAN THYMOCYTE CELL-SURFACE ANTIGENS T6, T9 AND T10 [J].
TERHORST, C ;
VANAGTHOVEN, A ;
LECLAIR, K ;
SNOW, P ;
REINHERZ, E ;
SCHLOSSMAN, S .
CELL, 1981, 23 (03) :771-780
[30]   ACCESSORY FACTORS INVOLVED IN MURINE T-CELL ACTIVATION - DISTINCT ROLES OF INTERLEUKIN-6, INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR [J].
VINK, A ;
UYTTENHOVE, C ;
WAUTERS, P ;
VANSNICK, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (01) :1-6